The present premise found that under hypoxic conditions, silencing Rap1b or Nrf2 inhibited the invasion of GC cells and co-silencing remarkably inhibited cell invasion, and GC patients in the Nrf2 (+) Rap1b (+) group had the worst prognosis. The gene discussed is RAP1B; the disease is gastric cancer.